Source: Annual Congress 2004 - Pathophysiology of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
O. Sanchez, E. Fadel, M. Humbert, P. Dartevelle, G. Simonneau, S. Adnot, S. Eddahibi (Creteil, Clamart, Le Plessis Robinson, France). Monocyte chemotactic protein-1 (MCP-1) synthesis and function in pulmonary artery smooth muscle cells (PA-SMCs) from patients with idiopathic pulmonary hypertension (IPH). Eur Respir J 2004; 24: Suppl. 48, 2696

Member's Comments

No comment yet.

Related content which might interest you: Arterial concentration of macrophage migration inhibitory factor (MIF) increases with exercise in patients with pulmonary hypertension (PH) Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 IL-6 receptor overexpression in pulmonary arterial smooth muscle cells in idiopathic pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Expression of macrophage migration inhibitory factor in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 PDGF promotes pulmonary artery smooth muscle cell proliferation and migration in pulmonary arterial hypertension Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF alveolar macrophages Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension}, Source: Eur Respir J 2012; 40: 886-894 Year: 2012 Neutrophil chemotaxis and adhesion in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 108s Year: 2001 Expression of platelet derived-growth factor (PDGF) in remodelled pulmonary arteries of COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002 Increased p130Cas activity induces smooth muscle cell proliferation and migration in idiopathic pulmonary arterial hypertension Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Arterial remodelling in patients with idiopathic pulmonary fibrosis (IPF) and the possible role of endothelial to mesenchymal transition (EndMT) Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 The role of growth and differentiation factor 15 (GDF-15) in the development of skeletal muscle wasting in pulmonary arterial hypertension (PAH) Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension Source: Eur Respir J 2007; 29: 937-943 Year: 2007 Vascular remodeling in chronic thromboembolic pulmonary hypertension: Involvement of dedifferentiated smooth muscle cells and C-reactive protein Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010 CD163 is expressed and modulated in human pulmonary artery smooth muscle cells: Implications for pulmonary artery hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Over expression of endothelin-1 (ET-1) in lung fibroblasts (LFb) from patients with pulmonary arterial hypertension (PAH), evidence for loss of inhibitory control Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 The influence of sera from interstitial lung diseases (ILD) patients on human mononuclear cells (MNC) production of vascular endothelial growth factor (VEGF) Source: Eur Respir J 2004; 24: Suppl. 48, 553s Year: 2004 Targeting CCR2 and CCR5 to inhibit macrophage/pulmonary artery smooth muscle cells cross-talk in pulmonary hypertension Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 Potential association between pulmonary hypertension in COPD and monocyte chemoattractant protein (MCP)-1 Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Effects of PEEP-like cyclic stretch on the IL-6 protein production in normal human pulmonary artery endothelial cells in vitro Source: Annual Congress 2012 - The many roads to lung injury Year: 2012 Fractalkine and its receptor (CX3CR1) in primary pulmonary hypertension (PPH) Source: Eur Respir J 2001; 18: Suppl. 33, 2s Year: 2001